| __timestamp | Merck & Co., Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 11606000000 | 1244910 |
| Thursday, January 1, 2015 | 10313000000 | 5029636 |
| Friday, January 1, 2016 | 9762000000 | 4846776 |
| Sunday, January 1, 2017 | 9830000000 | 5329003 |
| Monday, January 1, 2018 | 10102000000 | 7121000 |
| Tuesday, January 1, 2019 | 10615000000 | 9128000 |
| Wednesday, January 1, 2020 | 8955000000 | 10731000 |
| Friday, January 1, 2021 | 9634000000 | 10701000 |
| Saturday, January 1, 2022 | 10042000000 | 16121000 |
| Sunday, January 1, 2023 | 10504000000 | 37021000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. From 2014 to 2023, Merck & Co., Inc. and Viking Therapeutics, Inc. have taken distinct paths in optimizing these costs. Merck, a giant in the industry, consistently reported SG&A expenses in the range of $9 billion to $11 billion annually. Despite the high figures, Merck's expenses have shown a stable trend, reflecting its robust operational strategies.
On the other hand, Viking Therapeutics, a smaller player, has demonstrated a remarkable growth trajectory. Starting with SG&A expenses of just over $1 million in 2014, Viking's costs surged to nearly $37 million by 2023, indicating a strategic expansion phase. This 2900% increase highlights Viking's aggressive market positioning. As these companies continue to evolve, their SG&A strategies will be pivotal in shaping their financial futures.
Merck & Co., Inc. or argenx SE: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Madrigal Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Grifols, S.A.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Viridian Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Gilead Sciences, Inc. and Viking Therapeutics, Inc.
Incyte Corporation and Viking Therapeutics, Inc.: SG&A Spending Patterns Compared
Bio-Techne Corporation or Viking Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Viking Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Viking Therapeutics, Inc. or Catalyst Pharmaceuticals, Inc.
Viking Therapeutics, Inc. and Mesoblast Limited: SG&A Spending Patterns Compared
Viking Therapeutics, Inc. and Evotec SE: SG&A Spending Patterns Compared
Viking Therapeutics, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?